# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3796648 | F | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
2. | ALA3796649 | F | Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
3. | ALA3796650 | F | Cytotoxicity against mouse DLA cells after 48 hrs by MTT assay | Mus musculus | 13 | cell-based format | Scientific Literature | ||
4. | ALA3796651 | F | Cytotoxicity against human A549 cells after 48 hrs by LDH leak assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
5. | ALA3796652 | F | Cytotoxicity against human MCF7 cells after 48 hrs by LDH leak assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
6. | ALA3796653 | F | Cytotoxicity against mouse DLA cells after 48 hrs by LDH leak assay | Mus musculus | 13 | cell-based format | Scientific Literature | ||
7. | ALA3796696 | F | Cytotoxicity against human A549 cells after 48 hrs by trypan blue assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
8. | ALA3796697 | F | Cytotoxicity against human MCF7 cells after 48 hrs by trypan blue assay | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
9. | ALA3796698 | F | Cytotoxicity against mouse DLA cells after 48 hrs by trypan blue assay | Mus musculus | 13 | cell-based format | Scientific Literature | ||
10. | ALA3796699 | F | Antitumor activity against mouse DLA cells allografted in Swiss albino mouse assessed as inhibition of tumor growth at 75 mg/kg, ip administered as 3 doses on alternative days post 4 days of tumor implantation measured after final dose of drug challenge | Mus musculus | 1 | organism-based format | Scientific Literature | ||
11. | ALA3796700 | F | Decrease in ascites fluid secretion in Swiss albino mouse allografted with mouse DLA cells at 75 mg/kg, ip administered as 3 doses on alternative days post 4 days of tumor implantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
12. | ALA3796701 | F | Decrease in cell count Swiss albino mouse allografted with mouse DLA cells at 75 mg/kg, ip administered as 3 doses on alternative days post 4 days of tumor implantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
13. | ALA3796702 | F | Antitumor activity against mouse DLA cells allografted in Swiss albino mouse assessed as induction of tumor regression at 75 mg/kg, ip administered as 3 doses on alternative days post 4 days of tumor implantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA3796703 | F | Antitumor activity against mouse DLA cells allografted in Swiss mouse assessed as increase in animal survival time at 75 mg/kg, ip administered as 3 doses on alternative days post 4 days of tumor implantation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA3796704 | F | Antiangiogenic activity against Swiss albino mouse allografted with mouse DLA cells assessed as decrease in peritoneal angiogenesis measured as micro visual density | Mus musculus | 1 | organism-based format | Scientific Literature | ||
16. | ALA3796705 | F | Antiangiogenic activity in chicken chorioallantoic membrane assessed as inhibition of rVEGF-induced neovascularization measured upto 12 days | Gallus gallus | 1 | cell membrane format | Scientific Literature |